Wire Stories
-
484Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival...
-
379Propanc Biopharma Announces Strategic Pharma Partnering Initiative
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCBD) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering...
-
457ECI Appoints Jeff Schmidt as CEO to Lead the Company’s Next Phase of Growth
Schmidt brings decades of industry leadership, powerful background in cybersecurity, and impressive growth record to ECI BOSTON–(BUSINESS WIRE)–ECI, the leader in managed...
-
405Obsidian Solidifies Market Leadership Position, Expanding Posture Hardening Support to 11 New Applications
Removing the burden from its customers’ security teams, Obsidian seamlessly rolls out and integrates apps into existing SaaS postures NEWPORT BEACH, Calif.–(BUSINESS...
-
389Aera Technology to Deploy Decision Intelligence at Colgate-Palmolive
Worldwide Consumer Products Leader Chooses Aera Decision Cloud™ to Accelerate Complex Decisions for its Fast-Growing Hill’s Pet Nutrition Division MOUNTAIN VIEW, Calif.–(BUSINESS...
-
435Freshpet Provides Update on 2023 Annual Meeting of Stockholders
2023 Annual Meeting to be held in October Four director seats will be up for election SECAUCUS, N.J., June 06, 2023 (GLOBE...
-
376Draganfly Expands Collaboration with DSNS Emergency Services Ukraine, Delivering Effective Landmine Training and Demonstrations
Draganfly will continue to host more extensive training utilizing our full suite of landmine mapping technology, including our 3 XL drone and...
-
469Amphera Announces a Positive Opinion of the European Medicines Agency on the Granting of Orphan Medicinal Product Designation for MesoPher in Pancreatic Cancer
S-HERTOGENBOSCH, Netherlands–(BUSINESS WIRE)–Amphera B.V., a late-stage biotechnology company developing MesoPher cell therapy to treat cancer, today announces that the EMA Committee for...
-
427Enevate Appoints EV Battery Veteran Janis Doelle as VP, Sales and Marketing
IRVINE, Calif.–(BUSINESS WIRE)–Enevate, a pioneering battery innovation company featuring fast charge and high-density battery technologies for electric vehicles (EVs) and other markets,...
-
425St George’s Cancer Care Centre Becomes First Elekta Unity Site to Integrate ClearCalc
St George’s is the first cancer center in the world to leverage ClearCalc with Elekta’s MR-Linac technology. NEW YORK & CHRISTCHURCH, New...
